Mission
Mission
We develop better medicines to give patients a better life.
We develop better medicines to give patients a better life.
We Bridge
Molecules to Medicines
A leading pharma-bio company that develops drugs into medicines
We find new potential in research-stage chemicals and biologics.
Through formulation technology, we turn research-stage potential into actual medicines.
Better medicines raise patients' quality of life.
Develop the Potential.
Deliver the Medicine.
From research-stage drugs to approved medicines
Potential becomes medicine, and medicine becomes our history of growth.
The story of how Moogene Medi has found potential and turned it into medicine.
Moogene Medi took its first step at 5F, JW Building, 555 Nonhyeon-ro, Gangnam-gu, Seoul.
Earned Venture Company certification on the strength of our technology and growth potential.
Established a research center dedicated to proprietary formulation technology and product development.
Raised KRW 5 billion to advance technology development and expand the business.
Raised a KRW 3 billion follow-on round, strengthening our foundation for growth.
Listing on the KONEX market marked a new turning point in our growth.
Recognized for innovation and growth potential, we were selected for the Baby Unicorn 200 program.
Completed registration as a cosmetics responsible distributor to broaden our business.
Raised KRW 11.5 billion, accelerating the commercialization of our formulation technology.
Recognized for transparent, diligent disclosure practices.
Secured the manufacturing base to carry our research into a wider product range.
Received IND approval for the Phase 1/2a trial of HUTERA D, a treatment for androgenetic alopecia.
Signed co-development agreements with three Korean pharmaceutical companies for an androgenetic alopecia treatment.
Where our research and our partnerships take place.